Guardant Health partners with Quest for blood-based cancer screening
Go back to Guardant Health partners with Quest for blood-based cancer screening| Quest Diagnostics (NYSE: DGX) | Delayed: 240.35 +4.13 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $236.22 | 52 Week High | $86.85 | |||
| Open | $238.03 | 52 Week Low | $59.66 | |||
| Day High | $241.82 | P/E | 45.26 | |||
| Day Low | $236.27 | EPS | $5.31 | |||
| Volume | 374,392 | |||||
| Textainer Group Holdings limited (NASDAQ: GH) | Delayed: 158.13 -6.28 (3.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $164.41 | 52 Week High | $5.84 | |||
| Open | $163.79 | 52 Week Low | $5.49 | |||
| Day High | $168.97 | P/E | N/A | |||
| Day Low | $157.66 | EPS | $0.00 | |||
| Volume | 569,446 | |||||
